{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:02:39Z","timestamp":1787752959721,"version":"build-2784847793"},"reference-count":56,"publisher":"BMJ","issue":"11","funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Collins Family Fund"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2017,1,27]]},"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:p>Given increased awareness and improved non-invasive diagnostic tools, cardiac amyloidosis has become an increasingly recognised aetiology of increased ventricular wall thickness and heart failure with preserved ejection fraction. Once considered a rare disease with no treatment options, translational research has harnessed novel pathways and led the way to promising treatment options. Gene variants that contribute to amyloid heart disease provide unique opportunities to explore potential disease-modifying therapeutic strategies. Amyloidosis has become the model disease through which gene therapy using small interfering RNAs and antisense oligonucleotides has evolved.<\/jats:p>","DOI":"10.1136\/heartjnl-2016-309914","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T21:00:45Z","timestamp":1488488445000},"page":"812-817","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":31,"title":["Amyloid heart disease: genetics translated into disease-modifying therapy"],"prefix":"10.1136","volume":"103","clinical-trial-number":[{"clinical-trial-number":"nct02319005","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01960348","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01737398","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02627820","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Brett W","family":"Sperry","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H. Wilson","family":"Tang","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation, Center for Clinical Genomics, Cleveland, Ohio, USA"},{"name":"Department of Cardiovascular Medicine, Cleveland Clinic Foundation,, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,3,2]]},"reference":[{"key":"2025092002253528000_103.11.812.1","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/circ.104.14.1594","article-title":"Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts","volume":"104","author":"Liao","year":"2001","journal-title":"Circulation"},{"key":"2025092002253528000_103.11.812.2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijcard.2016.04.030","article-title":"Are classic predictors of voltage valid in cardiac amyloidosis? A contemporary analysis of electrocardiographic findings","volume":"214","author":"Sperry","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025092002253528000_103.11.812.3","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302353"},{"key":"2025092002253528000_103.11.812.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000152819.97857.9D"},{"key":"2025092002253528000_103.11.812.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"2025092002253528000_103.11.812.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2015.10.023"},{"key":"2025092002253528000_103.11.812.7","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.12.4.317"},{"key":"2025092002253528000_103.11.812.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"2025092002253528000_103.11.812.9","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308657"},{"key":"2025092002253528000_103.11.812.10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002877"},{"key":"2025092002253528000_103.11.812.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.596"},{"key":"2025092002253528000_103.11.812.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013354"},{"key":"2025092002253528000_103.11.812.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702133360703"},{"key":"2025092002253528000_103.11.812.14","first-page":"127","article-title":"A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology","volume":"47","author":"Jacobson","year":"1990","journal-title":"Am J Hum Genet"},{"key":"2025092002253528000_103.11.812.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.02.006"},{"key":"2025092002253528000_103.11.812.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404852"},{"key":"2025092002253528000_103.11.812.17","doi-asserted-by":"crossref","unstructured":"Dungu JN , Papadopoulou SA , Wykes K , et al . Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis. Circ Heart Fail 2016;9.doi:10.1161\/CIRCHEARTFAILURE.116.003352","DOI":"10.1161\/CIRCHEARTFAILURE.116.003352"},{"key":"2025092002253528000_103.11.812.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr383"},{"key":"2025092002253528000_103.11.812.19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/75.3.408"},{"key":"2025092002253528000_103.11.812.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70246-0"},{"key":"2025092002253528000_103.11.812.21","doi-asserted-by":"publisher","DOI":"10.1080\/13506120600876849"},{"key":"2025092002253528000_103.11.812.22","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.30.5.388"},{"key":"2025092002253528000_103.11.812.23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.738138"},{"key":"2025092002253528000_103.11.812.24","first-page":"1301","article-title":"Mechanisms of transthyretin amyloidogenesis. antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations","volume":"144","author":"Gustavsson","year":"1994","journal-title":"Am J Pathol"},{"key":"2025092002253528000_103.11.812.25","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-54"},{"key":"2025092002253528000_103.11.812.26","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20381"},{"key":"2025092002253528000_103.11.812.27","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"2025092002253528000_103.11.812.28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01591.x"},{"key":"2025092002253528000_103.11.812.29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-355784"},{"key":"2025092002253528000_103.11.812.30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1424"},{"key":"2025092002253528000_103.11.812.31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-618108"},{"key":"2025092002253528000_103.11.812.32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000890"},{"key":"2025092002253528000_103.11.812.33","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2016.1148025"},{"key":"2025092002253528000_103.11.812.34","doi-asserted-by":"publisher","DOI":"10.1038\/srep25080"},{"key":"2025092002253528000_103.11.812.35","doi-asserted-by":"publisher","DOI":"10.1038\/nature09494"},{"key":"2025092002253528000_103.11.812.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504942"},{"key":"2025092002253528000_103.11.812.37","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1602"},{"key":"2025092002253528000_103.11.812.38","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2016.1160882"},{"key":"2025092002253528000_103.11.812.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208760"},{"key":"2025092002253528000_103.11.812.40","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0326-6"},{"key":"2025092002253528000_103.11.812.41","doi-asserted-by":"publisher","DOI":"10.1515\/bmc-2013-0038"},{"key":"2025092002253528000_103.11.812.42","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20503"},{"issue":"Suppl 1","key":"2025092002253528000_103.11.812.43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/13506129.2012.673140","article-title":"Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy","volume":"19 Suppl 1","author":"Ackermann","year":"2012","journal-title":"Amyloid"},{"key":"2025092002253528000_103.11.812.44","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2016.1191458"},{"key":"2025092002253528000_103.11.812.45","doi-asserted-by":"crossref","first-page":"P7","DOI":"10.1186\/1750-1172-10-S1-P7","article-title":"Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis","volume":"10","author":"Benson","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"2025092002253528000_103.11.812.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.593"},{"key":"2025092002253528000_103.11.812.47","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/TP.0b013e3181f10edb","article-title":"Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure","volume":"90","author":"Dey","year":"2010","journal-title":"Transplantation"},{"key":"2025092002253528000_103.11.812.48","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajh.24433","article-title":"Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment","volume":"91","author":"Gertz","year":"2016","journal-title":"Am J Hematol"},{"key":"2025092002253528000_103.11.812.49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.7.4039"},{"key":"2025092002253528000_103.11.812.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2010.07.001"},{"key":"2025092002253528000_103.11.812.51","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.69"},{"key":"2025092002253528000_103.11.812.52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-535187"},{"key":"2025092002253528000_103.11.812.53","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2011.597464"},{"key":"2025092002253528000_103.11.812.54","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.chembiol.2014.09.009","article-title":"ATF6 activation reduces the secretion and extracellular aggregation of destabilized variants of an amyloidogenic protein","volume":"21","author":"Chen","year":"2014","journal-title":"Chem Biol"},{"key":"2025092002253528000_103.11.812.55","doi-asserted-by":"publisher","DOI":"10.1021\/ja505986a"},{"key":"2025092002253528000_103.11.812.56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11886-015-0653-1","article-title":"Emerging Advances in the Management of cardiac Amyloidosis","volume":"17","author":"Vranian","year":"2015","journal-title":"Curr Cardiol Rep"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2016-309914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:25:46Z","timestamp":1758360346000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2016-309914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,5,10]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1136\/heartjnl-2016-309914"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2016-309914","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}